HEAL vs. IDNA
HEAL (Global X HealthTech ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - HEAL tracks the Global X HealthTech Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, HEAL returned -13.37%/yr vs -7.52%/yr for IDNA. Their 0.70 correlation means they have sometimes moved together and sometimes differently. HEAL charges 0.50%/yr vs 0.47%/yr for IDNA.
Performance
HEAL vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HEAL achieves a -7.90% return, which is significantly lower than IDNA's 23.97% return.
HEAL
- 1D
- 0.07%
- 1M
- -7.11%
- 6M
- -5.44%
- YTD
- -7.90%
- 1Y
- -12.88%
- 3Y*
- -8.61%
- 5Y*
- -13.37%
- 10Y*
- —
- ALL TIME*
- -9.61%
IDNA
- 1D
- -1.40%
- 1M
- -7.39%
- 6M
- 13.88%
- YTD
- 23.97%
- 1Y
- 54.41%
- 3Y*
- 12.75%
- 5Y*
- -7.52%
- 10Y*
- —
- ALL TIME*
- 4.74%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $245.64K | $221.54K | $214.19K | |
| $842.73K | $1.44M | $1.52M |
HEAL vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HEAL Global X HealthTech ETF | -7.90% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 16.89% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 23.97% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 21.46% |
Correlation
The correlation between HEAL and IDNA is 0.55, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.55 |
Correlation (3Y) Balances recent behavior with more history. | 0.60 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.70 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2020 | 0.70 |
The correlation between HEAL and IDNA shifts across timeframes, from 0.55 (1 year) to 0.70 (all time), reflecting how their relationship changes across market environments.
HEAL vs. IDNA - Sectors Allocation Comparison
Sectors
HEAL
IDNA
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Utilities
-
-
Healthcare
HEAL
IDNA
Technology
HEAL
IDNA
-
Basic Materials
HEAL
-
IDNA
-
Communication Services
HEAL
-
IDNA
-
Consumer Cyclical
HEAL
-
IDNA
-
Consumer Defensive
HEAL
-
IDNA
-
Energy
HEAL
-
IDNA
-
Financial Services
HEAL
-
IDNA
-
Industrials
HEAL
-
IDNA
Real Estate
HEAL
-
IDNA
-
Utilities
HEAL
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HEAL vs. IDNA — Risk / Return Rank
HEAL
IDNA
HEAL vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X HealthTech ETF (HEAL) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HEAL | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.77 | ||
| Sortino ratioReturn per unit of downside risk | -3.77 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.34 | -0.42 |
| Calmar ratioReturn relative to maximum drawdown | -0.45 | 5.06 | -5.51 |
| Martin ratioReturn relative to average drawdown | -0.82 | 13.37 | -14.19 |
Loading charts...
Drawdowns
HEAL vs. IDNA - Drawdown Comparison
The maximum HEAL drawdown since its inception was -65.76%, roughly equal to the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for HEAL and IDNA.
Loading charts...
Drawdown Indicators
| HEAL | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.76% | -68.26% | +2.50% |
Max Drawdown (1Y)Largest decline over 1 year | -30.71% | -10.66% | -20.05% |
Max Drawdown (3Y)Largest decline over 3 years | -34.56% | -29.46% | -5.10% |
Max Drawdown (5Y)Largest decline over 5 years | -59.14% | -68.26% | +9.12% |
Current DrawdownCurrent decline from peak | -60.24% | -38.88% | -21.36% |
Average DrawdownAverage peak-to-trough decline | -43.48% | -36.30% | -7.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.87% | 4.03% | +12.84% |
Volatility
HEAL vs. IDNA - Volatility Comparison
The current volatility for Global X HealthTech ETF (HEAL) is 6.34%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 7.04%. This indicates that HEAL experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HEAL | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.34% | 7.04% | -0.70% |
Volatility (6M)Calculated over the trailing 6-month period | 17.24% | 18.24% | -1.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.70% | 25.03% | -2.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.63% | 28.50% | -1.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.25% | 29.44% | -3.19% |
HEAL vs. IDNA - Expense Ratio Comparison
HEAL has a 0.50% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
HEAL vs. IDNA - Dividend Comparison
HEAL's dividend yield for the trailing twelve months is around 0.27%, less than IDNA's 0.87% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
HEAL Global X HealthTech ETF | 0.27% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.87% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
HEAL and IDNA have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.04%) compared to HEAL (6.34%). In terms of maximum drawdown, HEAL dropped -65.76% vs IDNA's -68.26%.
On 5-year performance, IDNA leads with -7.52% vs -13.37% for HEAL. On fees, IDNA is cheaper at 0.47% per year. On volatility, HEAL has been the lower-risk option at 6.34%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IDNA has performed better with a -7.52% return vs -13.37%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.50% for HEAL.
IDNA has the higher dividend yield at 0.87%, compared with 0.27% for HEAL.
HEAL tracks Global X HealthTech Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for HEAL and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (2.17 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HEAL and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer